Alvin S. Parven, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 3,115 shares at $92.00 ($287K) on 2013-03-08, disclosed to the SEC on 2013-03-12.
Open-market sale of $287k ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALXN | SELL | 2016-08-24 | $2.1M | — | Filing → |
| ALXN | SELL | 2015-11-04 | $160K | — | Filing → |
| ALXN | SELL | 2014-11-13 | $2.9M | — | Filing → |